Results 351 to 360 of about 2,071,500 (370)

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Ca-A Cancer Journal for Clinicians, 2016
Lauren R Teras, Carol E Desantis, James R Cerhan   +2 more
exaly  

Multiple Myeloma: Charging Toward a Bright Future

Ca-A Cancer Journal for Clinicians, 2007
Parameswaran Hari
exaly  

Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine

Ca-A Cancer Journal for Clinicians, 2020
Adriana C Gamboa, Alessandro Gronchi, Kenneth Cardona   +2 more
exaly  

The cell biology of multiple drug resistance

Biochemical Pharmacology, 1987
openaire   +3 more sources

Understanding and addressing social determinants to advance cancer health equity in the United States: A blueprint for practice, research, and policy

Ca-A Cancer Journal for Clinicians, 2020
Kassandra I Alcaraz, K Robin Yabroff, Carmen E Guerra   +2 more
exaly  

Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society

Ca-A Cancer Journal for Clinicians, 2018
Timothy R Church, Christopher R Flowers, Carmen E Guerra   +2 more
exaly  

Transmissible Multiple Drug Resistance in Enterobacteriaceae

Science, 1972
Julian Davies, R. Rownd
openaire   +3 more sources

Multiple Drug Resistant Bacteria

Drug Discovery Today, 2003
openaire   +2 more sources

Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
William D Travis, Valerie W Rusch, Ramón Rami-porta   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Barata, Brian I Rini
exaly